A Sequential Approach to DME
Observational study examines whether a sequential steroid strategy could reduce injection burden in diabetic macular edema
Clinical Scorecard: A Sequential Approach to DME
At a Glance
| Category | Detail |
|---|
| Condition | Diabetic Macular Edema (DME) |
| Key Mechanisms | Combination of anti-VEGF injections and dexamethasone intravitreal implant to address vascular and inflammatory factors. |
| Target Population | Treatment-naïve patients with diabetic macular edema. |
| Care Setting | Ophthalmology clinics |
Key Highlights
- Sequential '1 + 1 + PRN' regimen showed comparable outcomes to standard '3 + PRN' protocol.
- Average of 2.6 injections required in the sequential group versus 4.9 in the conventional group.
- No significant differences in visual acuity or retinal anatomy between treatment groups.
- DME recurrence observed in three eyes with standard treatment, none in sequential regimen.
- Safety findings indicated manageable elevated intraocular pressure with no serious adverse events.
Guideline-Based Recommendations
Diagnosis
- Assess best-corrected visual acuity (BCVA) and central macular thickness (CMT).
- Utilize optical coherence tomography angiography (OCTA) for biomarker evaluation.
Management
- Consider sequential '1 + 1 + PRN' regimen for treatment-naïve DME patients.
Monitoring & Follow-up
- Regular follow-up for visual acuity, retinal anatomy, and intraocular pressure.
Risks
- Monitor for elevated intraocular pressure, although manageable with topical medication.
Patient & Prescribing Data
Newly diagnosed diabetic macular edema patients.
Early introduction of dexamethasone may reduce treatment burden and maintain outcomes.
Clinical Best Practices
- Implement a combination approach addressing both vascular and inflammatory components of DME.
- Evaluate patient response to treatment and adjust regimen as necessary.
Related Resources & Content
